1
Home
Companies

SomnoMed

SomnoMed
Leadership team

Mr. Neil Verdal-Austin B.Com., C.A. (Global CEO, MD & Director)

Mr. Hervé Fiévet (Global Chief Financial Officer)

Mr. Mark Harding (VP of Global Marketing)

Products/ Services
Health Care, Manufacturing, Medical, Medical Device
Number of Employees
100 - 500
Headquarters
North Sydney, New South Wales, Australia
Established
2004
Revenue
20M - 100M
Traded as
ASX:SOM
Social Media
URL
https://somnomed.com/au/
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorning Repositioner, which help return mandible back to its pre-treatment centric position; and SomTabs for cleaning oral devices. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.
History

SomnoMed was founded in 2004 in Sydney, Australia with a mission to advance the treatment of sleep disorders through the innovative use of medical devices. Currently, SomnoMed is a global leader in the treatment of obstructive sleep apnea (OSA) and snoring, both of which are serious medical conditions that can have significant impact on physical and mental health. The company’s innovative and patented range of mandibular advancement devices (MADs) offer comfortable, adjustable therapeutic solutions to treat sleep disordered breathing.

Mission
At SomnoMed, our mission is to help people sleep better. To do so, we provide innovative therapeutic solutions to treat sleep disorders while creating an environment of honesty, transparency and accountability.
Vision
At SomnoMed, our vision is to be the world leader in the sleep health industry by providing an array of products and services to improve the lives of those affected by sleep apnea and snoring.
Key Team

Mr. Matthew Conlon (Exec. VP Sales & Marketing - North America)

Mr. Marco Van Kleef (VP of Marketing & Sales - Europe)

Dr. Jagdeep Bijwadia (Chief Medical Officer)

Mr. Terence A. Flitcroft B.Com., B.Comm., C.A., CA, SF FIN (Company Sec.)

Dr. Peter Spencer MBA Ph.D., MAICD (Gen. Mang. of Operations)

Mr. Christopher Bedford (VP of Global Production and Product Devel.)

Recognition and Awards
SomnoMed has earned numerous awards for the development of its innovative products, including a World Class Medical Device Prize from the Australia and New Zealand Association, the Australian Institute of Management Innovation Awards and the Australian Medical Device of the Year Award.
References

https://in.investing.com/equities/somnomed-ltd

https://finance.yahoo.com/quote/SOMNF/profile?p=SOMNF

https://www.crunchbase.com/organization/somnomed

https://somnomed.com/au/

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

SomnoMed
Leadership team

Mr. Neil Verdal-Austin B.Com., C.A. (Global CEO, MD & Director)

Mr. Hervé Fiévet (Global Chief Financial Officer)

Mr. Mark Harding (VP of Global Marketing)

Products/ Services
Health Care, Manufacturing, Medical, Medical Device
Number of Employees
100 - 500
Headquarters
North Sydney, New South Wales, Australia
Established
2004
Revenue
20M - 100M
Traded as
ASX:SOM
Social Media
URL
https://somnomed.com/au/